ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
2025.02.26
VOLUNTARY ANNOUNCEMENT “ENOPARIN” OBTAINS APPROVAL FROM ARGENTINA
2025.02.26
ag真人平台官方:关于依诺肝素钠注射液获得阿根廷药品注册批件的公告
2025.02.18
VOLUNTARY ANNOUNCEMENT H1710 INJECTION RECEIVED THE NOTICE OF APPROVAL FOR CLINI...
2025.02.18
ag真人平台官方:关于获得药物临床试验批准通知书的公告
2025.02.14
VOLUNTARY ANNOUNCEMENT OBTAINING THE GMP CERTIFICATE FROM EMA
2025.02.14
ag真人平台官方:关于获得GMP证书的公告
2025.01.24
ag真人平台官方:2024年度业绩预告
2025.01.24
POSITIVE PROFIT ALERT ANNOUNCEMENT FOR THE ESTIMATED 2024 ANNUAL RESULTS
2025.01.02
ag真人平台官方:关于签订分销协议的公告
2025.01.02
VOLUNTARY ANNOUNCEMENT ENTERING INTO DISTRIBUTION AGREEMENT WITH YONGTAI PHARMAC...
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
Career Development
ag真人平台官方:Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.